Engineered immune cells as highly sensitive cancer diagnostics.

MLA

Aalipour, Amin, et al. “Engineered Immune Cells as Highly Sensitive Cancer Diagnostics.” Nature Biotechnology, vol. 37, no. 5, May 2019, pp. 531–39. EBSCOhost, https://doi.org/10.1038/s41587-019-0064-8.

APA

Aalipour, A., Chuang, H.-Y., Murty, S., D’Souza, A. L., Park, S.-M., Gulati, G. S., Patel, C. B., Beinat, C., Simonetta, F., Martinić, I., Gowrishankar, G., Robinson, E. R., Aalipour, E., Zhian, Z., & Gambhir, S. S. (2019). Engineered immune cells as highly sensitive cancer diagnostics. Nature Biotechnology, 37(5), 531–539. https://doi.org/10.1038/s41587-019-0064-8

Chicago

Aalipour, Amin, Hui-Yen Chuang, Surya Murty, Aloma L D’Souza, Seung-Min Park, Gunsagar S Gulati, Chirag B Patel, et al. 2019. “Engineered Immune Cells as Highly Sensitive Cancer Diagnostics.” Nature Biotechnology 37 (5): 531–39. doi:10.1038/s41587-019-0064-8.